In our patient, the cells showed a CD4-/CD8+ and CD56-negative phenotype, indicating that the tumor cells were predominantly cytotoxic T-cells (CD8+ T-cells), which are involved in mediating immune responses and killing tumor cells. This evidence concerns the gene CD8A and neoplasm.